Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 7
1994 5
1995 16
1996 34
1997 64
1998 121
1999 171
2000 258
2001 364
2002 489
2003 601
2004 795
2005 1088
2006 1090
2007 1281
2008 1409
2009 1460
2010 1568
2011 1544
2012 1677
2013 1736
2014 1617
2015 1724
2016 1668
2017 1641
2018 1702
2019 1563
2020 1109
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

23,562 results
Results by year
Filters applied: . Clear all
Page 1
PPAR gamma gene--a review.
Janani C, Ranjitha Kumari BD. Janani C, et al. Diabetes Metab Syndr. 2015 Jan-Mar;9(1):46-50. doi: 10.1016/j.dsx.2014.09.015. Epub 2014 Oct 13. Diabetes Metab Syndr. 2015. PMID: 25450819 Review.
This review highlights the roles that PPAR gamma play in the regulation of gene expression of multiple diseases including obesity, diabetes and cancer and highlights the gene isolation transformation role. Further studies are needed for the transformation of PPAR
This review highlights the roles that PPAR gamma play in the regulation of gene expression of multiple diseases including obes …
Fatty acids, eicosanoids and PPAR gamma.
Marion-Letellier R, Savoye G, Ghosh S. Marion-Letellier R, et al. Eur J Pharmacol. 2016 Aug 15;785:44-49. doi: 10.1016/j.ejphar.2015.11.004. Epub 2015 Nov 26. Eur J Pharmacol. 2016. PMID: 26632493 Review.
PPAR-γ and Wnt Regulate the Differentiation of MSCs into Adipocytes and Osteoblasts Respectively.
Li Y, Jin D, Xie W, Wen L, Chen W, Xu J, Ding J, Ren D. Li Y, et al. Curr Stem Cell Res Ther. 2018 Feb 23;13(3):185-192. doi: 10.2174/1574888X12666171012141908. Curr Stem Cell Res Ther. 2018. PMID: 29034841 Review.
OBJECTIVE: In this review, we focus on the ties of PPAR-γ and Wnt signaling in MSC differentiation into adipocytes and osteoblasts. RESULTS: Peroxisome proliferator-activated receptor-γ (PPAR-γ) is well established as a prime inducer of adipogenesis, while the Wnt p …
OBJECTIVE: In this review, we focus on the ties of PPAR-γ and Wnt signaling in MSC differentiation into adipocytes and osteoblasts. R …
PPAR Gamma and Angiogenesis: Endothelial Cells Perspective.
Kotlinowski J, Jozkowicz A. Kotlinowski J, et al. J Diabetes Res. 2016;2016:8492353. doi: 10.1155/2016/8492353. Epub 2016 Dec 7. J Diabetes Res. 2016. PMID: 28053991 Free PMC article. Review.
PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ.
Han L, Shen WJ, Bittner S, Kraemer FB, Azhar S. Han L, et al. Future Cardiol. 2017 May;13(3):279-296. doi: 10.2217/fca-2017-0019. Epub 2017 Jun 5. Future Cardiol. 2017. PMID: 28581362 Free PMC article. Review.
In mammals, the PPAR subfamily consists of three members: PPAR-α, PPAR-β/δ and PPAR-γ. PPARs control the expression of a large number of genes involved in metabolic homeostasis, lipid, glucose and energy metabolism, adipogenesis and inflammation. ...Th …
In mammals, the PPAR subfamily consists of three members: PPAR-α, PPAR-β/δ and PPAR-γ. PPARs control the express …
Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation.
Villapol S. Villapol S. Cell Mol Neurobiol. 2018 Jan;38(1):121-132. doi: 10.1007/s10571-017-0554-5. Epub 2017 Oct 3. Cell Mol Neurobiol. 2018. PMID: 28975471 Free PMC article. Review.
Peroxisome proliferator-activated receptor gamma (PPARγ) has been implicated in the pathology of numerous diseases involving diabetes, stroke, cancer, or obesity. ...
Peroxisome proliferator-activated receptor gamma (PPARγ) has been implicated in the pathology of numerous diseases involving diabetes …
6-Shogaol attenuates LPS-induced inflammation in BV2 microglia cells by activating PPAR-γ.
Han Q, Yuan Q, Meng X, Huo J, Bao Y, Xie G. Han Q, et al. Oncotarget. 2017 Jun 27;8(26):42001-42006. doi: 10.18632/oncotarget.16719. Oncotarget. 2017. PMID: 28410218 Free PMC article.
In addition, 6-Shogaol could increase the expression of PPAR-γ. Moreover, inhibition of PPAR-γ by GW9662 could prevent the inhibition of 6-Shogaol on LPS-induced inflammatory mediator production. In conclusion, 6-Shogaol inhibits LPS-induced inflammation by activati …
In addition, 6-Shogaol could increase the expression of PPAR-γ. Moreover, inhibition of PPAR-γ by GW9662 could prevent the inh …
Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present).
Takada I, Makishima M. Takada I, et al. Expert Opin Ther Pat. 2020 Jan;30(1):1-13. doi: 10.1080/13543776.2020.1703952. Epub 2019 Dec 18. Expert Opin Ther Pat. 2020. PMID: 31825687 Review.
Many synthetic ligands for PPARs have been developed to expand their therapeutic applications.Areas covered: The authors searched recent patent activity regarding PPAR ligands. ...Methods for the combination of PPAR ligands with other drugs and expanded application …
Many synthetic ligands for PPARs have been developed to expand their therapeutic applications.Areas covered: The authors searched recent pat …
The role of peroxisome proliferator-activated receptor gamma in prostate cancer.
Elix C, Pal SK, Jones JO. Elix C, et al. Asian J Androl. 2018 May-Jun;20(3):238-243. doi: 10.4103/aja.aja_15_17. Asian J Androl. 2018. PMID: 28597850 Free PMC article. Review.
One promising target is the peroxisome proliferator-activated receptor gamma (PPARγ) protein. PPARγ was originally thought to act as a tumor suppressor in prostate cells because agonist ligands inhibited the growth of prostate cancer cells; however, additional studies foun …
One promising target is the peroxisome proliferator-activated receptor gamma (PPARγ) protein. PPARγ was originally thought to act as …
23,562 results
Jump to page
Feedback